Found: 7 articles
Article | Edition |
---|---|
R.S. Pesotsky, V.F. Semiglazov, A.I. Tseluyko, M.D. Sokolova, V.V. Mortada, T.T. Tabagua, P.V. Krivorotko
Treatment of HER2-positive early (minimal) breast cancer
|
№7 / 2022 |
V.F. Semiglazov (1), V.V. Semiglazov (2), K.S. Nikolaev (1), A.V. Komyakhov (1), T.Yu. Semiglazova (1), R.M. Paltoev (1), R.V. Donskikh (1), A.I. Tseluyko (1), A.S. Artemyeva (1), V.O. Bashlyk (1), G.F. Miryusupova (3), G.A. Dashyan (1)
DE-ESCALATION AND ESCALATION OF TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER
|
№17 / 2017 |
L.G. Zhukova, I.P. Ganshina, V.G. Zaitsev, M.V. Stepanchenko
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
|
№8 / 2016 |
G.Z. Mukhametshina (1), E.V. Lubennikova (2), M.R.Lichinitser (2)
15-YEAR EXPERIENCE WITH THE USE OF HERCEPTIN IN HER2-POSITIVE BREAST CANCER
|
№18 / 2015 |
V.F. Semiglazov (1), V.V. Semiglazov (2), K.S. Nikolaev (1), G.A. Dashyan (1), R.M. Paltuev (3)
COMPLEX THERAPY OF HER2-POSITIVE BREAST CANCER
|
№8 / 2015 |
L.G.Zhukova, M.R. Lichinitser
Adjuvant Therapy With Trastuzumab For Early-stage Breast Cancer: 12 Or 24 Months (based On Esmo Data, Vienna, October, 2012)
|
№18 / 2012 |
T.Yu Semiglazova, L.V. Filatova, D.Kh Latipova, M.L. Gershanovich
Target Therapy Her2-positive Breast Cancer With Brain Metastases: New Prospects For Treatment
|
№17 / 2010 |